News
In May 2025, the Journal for ImmunoTherapy of Cancer published a pioneering study entitled "NeoPred: dual-phase CT AI forecasts pathologic response to ...
ANGLE presents new data at EACR 2025 DEMONSTRATING DNA DUAL ANALYSIS FOR COMPREHENSIVE LIQUID BIOPSY PROFILING Poster highlights ANGLE's combined CTC-DNA and ctDNA analysis revealing tumour ...
Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...
Immunotherapy before surgery improves lung cancer survival in global clinical trial - Medical Xpress
Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard ...
Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.
May 31 (Reuters) - Exposure to wildfire smoke may increase lung cancer patients' risk of dying from their disease, particularly among non-smokers, but the effect may be mitigated by certain cancer ...
Pts underwent serial blood collection prior to initiation of treatment, 2-4 weeks after treatment initiation and approximately 6-8 weeks thereafter until progression. 5-10 ng of cfDNA was isolated ...
Dana-Farber Cancer Institute researchers have launched a study of a novel, homegrown blood test in hopes of identifying people who are at an elevated risk of lung cancer – despite never having ...
Lung cancer leads global cancer mortality, and non-small-cell variants make up more than 80% of cases. Immune checkpoint inhibitors have transformed therapy yet help only 27–45% of recipients.
9 out of 51 in the nation for lung cancer screening at 20.0%, and among the better in the U.S. Lung cancer screening with annual low-dose CT scans for those at high risk can reduce the lung cancer ...
The study was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, SU2C Lung Cancer Interception Dream Team Grant; Stand Up to Cancer-Dutch Cancer Society International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results